The moderate and informed consumption of Generation Z is reshaping the cannabis retail experience, valuing routine, self-care, and new, more functional forms of use.

Report indicates sector will grow at an annual rate of 14.53%, driven by legalization and consumers seeking healthier alternatives

Report indicates sector will grow at an annual rate of 14.53%, driven by legalization and consumers' search for healthier alternatives

The agency determined the suspension of the commercialization and advertising of all items from the brands Golden CBD Plus and Golden CBD+ Nanotech in the national territory.

California's new law aims to expedite research on cannabis and psychedelics for the treatment of opioid dependence, brain injuries, PTSD, and other mental health conditions that particularly affect war veterans

Research in the USA reveals an increase in cannabis consumption among people with diabetes and raises concerns about health impacts and the need for clinical guidelines

Experts point out that the US experience can accelerate national development

Despite the sector's strong performance in July, Alan Brochstein points out risks and uncertainties for major multi-state operators.

Bill regulating psilocybin therapy advances in New Jersey, allowing supervised use of the substance for therapeutic purposes

With the drug Ver-01, the entrepreneur aims to offer a safe and effective alternative for the treatment of chronic pain, targeting a $20 billion market dominated by opioids

The safety and efficacy of cannabis-based products depend on an integrated chain involving chemists, biomedicals, pharmacists, and doctors — professionals who ensure, at each stage, the quality, stability, and trust in patient treatment

Bipartisan proposal considers that the already consolidated market can be controlled by clear rules, instead of being banned in the state

Coalition accuses retailers of marketing marijuana as hemp and operating outside the regulated market

Scientific Committee maintains technical rigor and focuses on a forward-looking program in the 5th edition of the event in São Paulo

Experiment aims to expose plants to microgravity for nine months after capsule recovery failure in 2025

Proposal creates a legal framework for production, importation, and self-cultivation; the report included strict security requirements for the medicinal use of cannabis

While the global index declines, the ETF MSOS accumulates significant gains in 2025, driven by expectations of changes in Section 280E

Financial contributions from major companies in the sector occurred months before the president's executive measure, aiming for a change in federal legislation

Agency presents new report with no defined timeline, while experts warn that moving to Schedule III would have profound impacts on research and taxation, but not federal legalization

Global Index falls by 4.2% during the year, but American operators diverge from the global scenario and show significant growth